IL2 and COVID-19: As reported in our prior study, at 13 months after discharge, 11.6% of the HCWs with severe COVID-19 had elevated IL-6, and more than 98% had normal levels of the remaining five cytokines (IFN-γ, IL-10, IL-2, IL-4 and TNF-α) (4).